Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
OS ›
OSTEOVANCE
Trademark search for:
OSTEOVANCE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-11-24 — Application filed
2017-05-11 — Sn assigned for sect 66a appl from ib
2017-05-12 — Application filed
2017-05-12 — Assigned to examiner
2017-05-16 — Application filed
2017-05-16 — Final disposition recorded
2017-05-17 — Office action issued
2017-06-02 — Office action issued
2017-06-02 — Office action issued
2017-06-24 — Office action issued
2017-07-31 — Office action issued
2017-08-22 — Assigned to lie
2017-08-24 — Correspondence received in law office
2017-08-24 — Teas/email correspondence entered
2017-09-06 — Approved for pub - principal register
2017-09-20 — Notification of notice of publication e-mailed
2017-09-22 — Teas revoke/app/change addr of atty/dom rep received
2017-09-22 — Attorney/dom.rep.revoked and/or appointed
2017-10-04 — Notice of start of opposition period created, to be sent to ib
2017-10-04 — Notification of possible opposition sent to ib
2017-10-06 — Teas post publication amendment received
2017-10-10 — Official gazette publication confirmation e-mailed
2017-10-10 — Published for opposition
2017-10-18 — Assigned to petition staff
2017-10-20 — Post publication amendment - entered
2017-10-21 — Notification processed by ib
2017-12-26 — Registered-principal register
2018-03-26 — Final disposition recorded
2018-04-05 — Final disposition recorded
2018-04-05 — Final disposition recorded
2018-05-19 — Final disposition recorded
2022-06-25 — New representative at ib received
2022-12-26 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2023-03-12 — New representative at ib received
2023-07-24 — New representative at ib received
2023-08-07 — Teas revoke/app/change addr of atty/dom rep received
2023-08-07 — Attorney/dom.rep.revoked and/or appointed
2023-08-07 — Teas change of domestic representatives address
2023-08-07 — Teas change of correspondence received
2024-07-12 — Cancelled section 71
2024-07-12 — Final status recorded
2025-03-12 — Total invalidation of reg ext protection created
2025-06-04 — Invalidation processed
2025-06-05 — Total invalidation of reg ext protection sent to ib
2025-06-20 — Total invalidation processed by the ib
Owner Information
Australian Biotechnologies Pty Limited
AU
Australian Biotechnologies Pty Limited
AU
Australian Biotechnologies Pty Limited
AU
Correspondent
Jami A. Gekas Foley & Lardner LLP 321 North Clark Street Suite 3000 Chicago, IL 60654-4762
Filing Details
Filing Date:
2016-11-24
Status Date:
2024-07-12
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.